ClinicalTrials.Veeva

Menu

Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)

A

Aristotle University Of Thessaloniki

Status

Completed

Conditions

Diabetes Mellitus Type 2
Insulin Resistance
Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT01121172
10012010

Details and patient eligibility

About

The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents.

So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.

Enrollment

180 patients

Sex

All

Ages

2 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Obese children and adolescents (aged 2-16 years old)

Exclusion criteria

  • Chronic diseases
  • Hypothyroidism
  • Medication

Trial design

180 participants in 2 patient groups

obese
Description:
obese subjects according to International Obesity Task Force criteria
lean

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems